Abstract Epistaxis is defined as flow of blood from the nasal fossae and is a common and benign disorder in the great majority of cases which does not require medical care. It may however become a genuine medical or surgical emergency because of the amount, repeated episodes or patient's medical vulnerability (such as coronary artery disease patients). Epistaxis may be either primary or a symptom of an underlying disease. Four levels of problems need to be answered faced with epistaxis: recognizing it, and in particular not missing ''epistaxis'' due to swallowed blood or venous hemorrhage, which falls outside of the scope of interventional radiology; establishing the amount and its repercussions, particularly as a decompensating factor in another disease; investigating its cause and in particular never missing a tumor (male adolescents); obtaining hemostasis. Epistaxis varies not only in type and cause but must be considered in its clinical context. Arterial embolization is a treatment of choice for severe refractory epistaxis and some hemorrhages. When carried out by trained operators, it is an effective method with few risks of complications and is increasingly being used in reference centers (Brinjikji et al.). It remains, however, a method which is less widely used than surgery, particularly in the United States where in a series of 69,410 patients treated over the last 10 years for refractory epistaxis, 92.6% underwent surgical ligation, 6.4% embolization and 1% combined treatments (Brinjikji et al.). Epistaxis is occasionally catastrophic and requires extremely urgent management. In each case, close collaboration with the surgeon, the presence of an intensive care anesthetist and at least sedation are all factors which improve management and therefore the results of embolization. All patients and/or their friends/close family should have given ''reliable, clear and appropriate'' information.
General points
Epistaxis has a prevalence of approximately 60% in the adult population and is the commonest acute disorder seen in ear-nose and throat clinical practice. The natural history of epistaxis is that it recovers untreated in the great majority of cases. According to Small et al. [1] , only 6% of cases of epistaxis require medical treatment although some may be fatal without treatment.
The causes can be divided into two subgroups: an idiopathic (or essential) group and a ''symptomatic'' group in which the epistaxis is the symptom of an underlying disease.
More than 70% of cases are ''idiopathic'' or ''essential'' [2] . The majority of cases of essential epistaxis are related to risk factors [3] , which are hypertension, hypercholesterolemia, smoking, the NSAID (mostly aspirin) and coagulation disorders. The organic causes of symptomatic epistaxis (Fig. 1) are trauma, surgery particularly trans-sphenoidal [4] , ENT tumors, malformations such as hereditary hemorrhagic telangiectasiae (RenduOsler disease) [5] or occasionally carotid-cavernous sinus fistulae [6] .
Regardless of the cause, epistaxis can be serious and life threatening. When it is first seen, it is important to assess the amount and repetition of blood losses and carry out a general laboratory assessment (coagulation, complete blood count and grouping). In severe epistaxis, patients should be managed in a specialist ENT unit.
Practical radiological anatomy
A full knowledge of the branches of the external carotid artery is an essential. These should be identified by conventional angiography after selective catheterization of the external carotid artery (Figs. 2-10 ).
Normal radiological anatomy
The sphenopalatine artery is the artery usually responsible for refractory epistaxis. This can be occluded surgically through an endonasal approach or it can be embolized. Possible hazardous anastomoses with branches of the external carotid artery can result in visual or central deficits per-or post-embolization.
The vascular blush is an anastomotic plexus made up of arterial branches (second order) from the external carotid artery, described by Kiesselbach. This is located in the antero-inferior part of the nasal septum and is the site of over 90% of epistaxis. The sphenopalatine artery is its main blood supply ( Fig. 3 ) and this is therefore the artery most often involved in idiopathic epistaxis.
Other branches of the maxillary artery should also be understood. 
Anastomoses between internal and external carotid artery territories
A variable number of anastomoses exist between branches of the internal and external carotid arteries (aIC-aEC) carrying a risk of neurological accidents with off-target embolization. These ''hazardous'' anastomoses should always be looked for (Fig. 11) . Only the ethmoidal arteries routinely contribute to the vascular supply of the nasal fossae. The anterior and posterior ethmoidal arteries arise from the ophthalmic artery (which itself is the first collateral branch of the internal carotid artery) and supply the upper part of the superior nasal concha and the most superior part of the nasal fossae.
The place of diagnostic imaging
A routine supra-aortic vessel CT angiogram (SAOV) is recommended before any treatment procedure. If the epistaxis is deemed to be severe, treatment should be given without delay.
This must include an image in the arterial phase and an image in the tissue phase. These have two uses:
• etiologic: they can be used to investigate for an underlying disease as the cause of the epistaxis (symptomatic epistaxis):
• tumor: investigation for a mass in the nasal fossae or cavum or vascular lesions (wall irregularities, pseudoaneurysm), . After its origin, it travels vertically in the infratemporal fossa entering the cranium (c: arrows) through the spinous foramen and supplies the dura mater. It is not responsible for epistaxis and does not require embolization in this situation. Its anatomical position generally allows it to be preserved. The infra-orbital artery arises from the distal portion of the internal maxillary artery and enters the infra-orbital canal where it travels jointly with the infra-orbital nerve (a branch of V2). Before emerging through the infra-orbital foramen, it divides into an orbital branch supplying the inferior rectus muscle and the lachrymal sac and an anterior branch supplying the superior dental tissues and maxillary sinus mucosa. Some of its branches may anastomose superiorly with the facial artery (through the angular artery) or the ophthalmic artery (through dorsal nasal branches of the ophthalmic artery). It is not therefore directly responsible for posterior epistaxis but because of its anatomical site, it is rarely preserved. and axial (c) reconstruction. Descending palatine artery arises from the distal portion of the internal maxillary artery (a: arrow), crosses the maxillary nerve (V2) next to the pterygopalatine ganglion in the pterygopalatine groove (b: arrowhead) and gives rise to a descending vertical portion (b: arrow) in the greater palatine nerve canal (c: arrow) where it travels together with the nerve carrying the same name. It supplies the propharyngeal mucosa in the soft palate and upper gums. It is therefore not directly responsible for posterior epistaxis but because of its anatomical site, it is rarely preserved. • vascular malformation: investigation for arteriovenous shunts, • rendu-Osler disease: investigation for telangiectasiae, • post-traumatic or postoperative: investigation for an active leak, pseudoaneurysms or wall irregularities;
• preoperative:
• with a view to endovascular treatment: anatomy of the SAOV, atheroma (risk of CVA), • with a view to surgery: identification of the sphenopalatine foramen and ethmoidal arteries. CT angiography is usually normal in essential epistaxis.
Assessment of severity
Before any treatment is given, it is essential to define whether the epistaxis is mild or severe. Diagrammatically, two clinical pictures can be distinguished.
Mild epistaxis
Blood flow is not particularly heavy and comes in drops from the nostril. It almost always begins unilaterally. ORL examination is straightforward after the patent has wiped their nose and anterior rhinoscopy shows the site of the bleeding, which is generally anterior in Kiesselbach's plexus. This has no consequences on the patient's general condition.
Severe epistaxis
The severity of epistaxis depends on different factors, which should be assessed immediately:
• the presence of hemorrhagic shock;
• a fall in hemoglobin: epistaxis is deemed to be severe if the blood hemoglobin is under 8 g; • the amount: this is not so much assessed by whether the epistaxis is bilateral or anteroposterior but using objective concepts such as heart rate (pulse), blood pressure, sweating and pallor. Volume is always difficult to estimate and is often over-estimated by the patient or the patient's friends/family, but can be underestimated if it is swallowed; • the duration or repetition of epistaxis should be confirmed; • association with a disease liable to decompensate because of blood loss such as coronary artery disease or carotid artery stenosis; • the presence of coagulation abnormalities (such as anticoagulation therapy) occasionally makes control of the bleeding more difficult.
The nasal cavities are occasionally difficult to examine because of the amount of the bleed which is often bilateral and anteroposterior.
Treatment of essential epistaxis
This depends on how benign or severe the epistaxis is.
If the epistaxis is symptomatic, treatment is that of the underlying cause, which will be discussed in the next section.
If the epistaxis is benign
The treatments follow a ''crescendo'' sequence, increasing in step in the following order:
Local treatment: ''minor measures'': • manual bidigital compression for very anterior bleeding;
• anterior meshing by applying hemostatic meshes (Merocel ® );
• endoscopic electrocoagulation with bipolar diathermy forceps under local anesthesia if an anterior lesion is visible; • if this fails:
• anteroposterior tamponade: this is usually a treatment for posterior rather than anterior epistaxis. In the latter situation, anterior and posterior tamponade should be applied using a dual balloon tube (Fig. 12) ; • if this fails:
• here again, posterior epistaxis is usually the cause,
• anteroposterior tamponade may be ineffective in a number of cases (25 to 52% depending on the series), this is defined as failure of two posterior tamponades over 48 h, • in this situation, the epistaxis is said to be refractory and is deemed to be severe. This therefore requires surgery or endovascular treatment.
If the epistaxis is deemed to be severe from the outset (or refractory)
In practice, severe epistaxis should be treated initially by anteroposterior tamponade.
If it is life threatening (hemorrhagic shock, fall in hemoglobin to under 8 g), if bleeding persists (refractory epistaxis) or on a background of a very serious underlying cause, it should be treated surgically (electrocoagulation of the sphenopalatine artery) or through an endovascular radiological approach (arterial embolization).
If anterior tamponade fails, the dual balloon tube is introduced as far as the rhinopharynx (Fig. 12) . The posterior balloon (arrow) is inflated moderately and blocked in the choana. The anterior balloon (arrowhead) is then inflated in the vestibule of the nostril to isolate the whole nasal fossa. The balloons should be filled with water and deflated every 6 hours to avoid mucosal necrosis.
Surgery
Surgery can be useful for uncontrolled bleeding. Different types of surgery are possible: endonasal electrocoagulation of the sphenopalatine artery ( Fig. 13 ) involves using bipolar diathermy forceps to coagulate the sphenopalatine artery at its emergence (sphenopalatine foramen) into the posterior part of the nasal fossa and is effective in 75% to 85% of cases (or even more in very experienced hands). Its limitations are mucosal damage making it difficult to view the artery and heavy bleeding due to blood coagulopathies.
The ethmoidal arteries are usually ligated if embolization fails if post-embolization views show revascularization of the nasal fossa by the anterior or posterior ethmoidal artery.
Ligation of the anterior ethmoidal artery is usually performed by a surgical approach through the surgical approach internal canthus rather than endonasally. The posterior ethmoidal artery is ligated in recurrence of bleeding despite ligating the anterior ethmoidal artery.
Ligation of the external carotid artery through cervicotomy is a technique which has now been abandoned except in very rare cases as it obstructs access to future embolization. Ligating the internal maxillary artery through a vestibular approach is a demanding technique which is poorly suited to emergency use and is rarely carried out.
Endovascular treatment
Anterior essential epistaxes are not treated by embolization unless symptomatic treatment and/or surgery have failed. Posterior epistaxis is a good indication for embolization [8] (Fig. 14) if the epistaxis is severe from the outset (hemorrhagic shock or large fall in hemoglobin with a hemoglobin of under 8 g) or if two posterior tamponades have failed over more than 48 hours (refractory epistaxis).
Embolization technique: • femoral approach with a valve introducer (6F if possible);
• selective catheterization of the common internal and external carotid artery (if possible using a guide catheter) ipsilateral to the bleeding (and possibly contralateral if the bleeding side is not identified on ENT examination); • microcatheterization (0.021 inch) of the arteries to be embolized. Flexible ''navigating'' microcatheters should be used in preference to avoid arterial spasm.
The arterial architecture and bleeding areas should be identified on anteroposterior and lateral views. Anastomoses with the cerebral or ophthalmic arterial territories must be identified, together with those between the Figure 14 . Topography of the arteries usually embolized for refractory epistaxis, from Christensen et al. [10] .
sphenopalatine and anterior ethmoidal arteries via the turbinate and infra-orbital arteries. Catheterization of arteries to the neck (subclavian artery and its branches) is generally not required in idiopathic epistaxis although is essential in other cases of ENT hemorrhage, particularly postoperatively in patients who have undergone laryngectomy and are bleeding from their tracheostomy cannula.
Hemorrhage from the anterior ethmoidal artery requires surgical treatment and is not treated endovascularly because of the dangers associated with microcatheterizing the ophthalmic artery.
Embolization of the ipsilateral sphenopalatine artery is sufficient in most cases and may be combined with embolization of the ipsilateral facial artery (Fig. 15) , which is very often anastomosed with the sphenopalatine artery through the infra-orbital artery (which significantly reduces the recurrence of hemorrhage) (Fig. 5) . In bilateral epistaxis, both sphenopalatine and facial arteries may be embolized.
In some cases, other branches of the external carotid artery may restore flow to the ending of the sphenopalatine artery and the internal maxillary artery through countercurrent anastomoses. These only occasionally develop after occlusion of the main trunk and can then be catheterized and occluded.
Occlusion materials
The choice of occlusion material depends mostly on the cause of the epistaxis. Microparticles are preferable in most cases of essential epistaxis when non-resorbable microparticles with a diameter of over 500 microns in size are extremely effective. These should however be avoided if anastomoses are present between the sphenopalatine territory and the territory of the anterior ethmoidal artery, particularly if these two territories are contributing to the epistaxis. In order to be used, they require free-flow injection and radioscopy monitoring to avoid any risk of reflux and to identify anastomoses which are unmasked secondarily. These microparticles can cause complications during embolization of the facial artery (skin necrosis and pain).
Insertion of microcoils may be a good alternative: these are either ''flushable'' or controlled release. They should Figure 15 . Embolization of essential refractory epistaxis. Eighty-two-year-old female patient with left refractory essential epistaxis despite correct medical treatment. Left common carotid arteriography (a) shows vascularization of the posterior nasal fossa mostly through branches of the internal maxillary artery but also from branches of the ophthalmic artery (a: ethmoidal) and to a lesser extent by branches of the facial artery. Hyperselective arteriography of the internal maxillary artery (b) shows modal anatomy and no anastomoses seen in the internal carotid artery territory, particularly the ophthalmic region. A repeat view after ipsilateral embolization of the internal maxillary artery with 700 m microparticles (Embozen ® Microspheres, CeloNova Biosciences Inc, San Antonio, Tx, USA) shows complete devascularization of the nasal fossa as a result of obstruction of the maxillary artery (black arrowheads). A per-procedure clinical check by the surgical team confirmed the immediate success of the procedure.
be positioned distally in contact with the hemorrhagic area. They have the disadvantage of permanently obstructing the artery and occluding one of the targets for possible reembolization in the event of a recurrence.
Cyanoacrylate glues (Glubran 2 ® or Histoacryl ® ) are difficult to use and require operators trained in their use [7] . They are immediately effective but are reserved for life-threatening cases. Embolization with Onyx ® is more straightforward and carries less risk of off-target embolization than the cyanoacrylates. This requires good knowledge of the toxicity and delivery of the substance [8] . When it is used in branches of the internal maxillary artery, the dimethylsulfoxide contained in Onyx ® can cause profound bradycardia due to a trigemino-cardiac reflex [9] .
Results: success, recurrence and complications
The technical success rate of embolization is high, in the region of 80 to 88% [10] . Complications may occur in 8%-13% of cases [10] [11] [12] . The most recent studies show better results probably due to advances in techniques, operators, the materials available to them and embolization agents (microcoils, microparticles, etc.).
There is a wide range of potential complications after endovascular treatment of epistaxis. In addition to recurrence of hemorrhage, the literature reports cases of facial neuralgia, septal perforation, sinusitis, and otitis media. Systemic complications may also occur, including inhalation hypoxia, hypovolemia, angina and/or myocardial infarction. The meta-analysis reported by Cullen on 539 patients not only identified the different complications of endovascular treatment but compared their incidence with those of surgery [13] .
The most severe complications of arterial embolization are cerebrovascular accident and obstruction of the central artery of the retina. Depending on the series, these occur in between 0 and 2% of cases [14] . In Brinjikji's retrospective analysis [15] on a population of 64,289 patients treated in the United States between 2003 and 2010, the CVA rate was found to be significantly higher after embolization (0.9%) than after surgery (0.1%) (Fig. 16) .
These results raise questions. It is likely that the increasing use of minimally invasive endoscopic techniques to ligate the sphenopalatine artery is improving patient management and secondly, the experience of interventional radiologists, the state of the patient's arterial system and embolization agents are all factors which influence development of CVA. Only a few authors have produced a critical analysis of the embolization materials and agents used in this situation. Routine use of microcatheterization is contributing towards a reduction in the incidence of CVA [3] .
In terms of procedure costs, data from the studies are controversial probably because of the differences in price of the various embolization agents which can be used and differences in cost of the radiology and surgical environments. Embolization appears to be more expensive in surgery [16] , although this excess cost is usually compensated by shorter hospitalization stays for embolization [17] .
Early rebleeding after embolization is usually treated by further embolization unless blood flow has obviously been restored through the ethmoidal arteries. Collateral vessels are examined angiographically (the anterior ethmoidal and contralateral external carotid arteries). Occlusion of the two facial arteries and two sphenopalatine arteries is a possible option. CVA due to off-target embolization is managed conventionally.
Post-embolization neuropathy is treated with corticosteroids.
Secondary epistaxis Embolization of branches of the external carotid artery in ENT oncology
Epistaxis generally involves neoplastic sites in the nasopharynx (Fig. 17) . The incidence of this complication is low in cervicofacial surgery (4.3%) [17] although external radiotherapy increases the risk by a factor of 7.6 [18, 19] .
The bleeding may arise from the tumor by erosion of vascular structures which are invaded, particularly in progressive disease [22] , but may occur as a result of tumor necrosis in patients who have responded very well to treatment. The hemorrhage may occur on a background of complete remission as a result of irradiation-induced damage, in which case it is promoted by a local inflammatory factor (osteoradionecrosis, tracheostomy cannula, orostome). Occasionally, hemorrhage in the postoperative period may be due to loosening of a vascular structure (reconstruction flap). Endovascular (hemostatic) treatment is an option with a recognized indication [18] . The general principles of embolizing branches of the external carotid artery are the same as for essential epistaxis (Appendix).
Rendu-Osler disease
Rendu-Osler disease or hereditary hemorrhagic telangiectasiae is an autosomal dominant transmitted angiomatosis belonging to the phacomatoses group. It is managed in a multidisciplinary setting in a local or regional center.
Epistaxis is the most common clinical feature and recurs frequently.
ENT embolization is only considered in patients with frequent episodes of bleeding who cannot live a satisfactory everyday life. Embolization is performed by microparticles (between 500 and 700 m in size) (Fig. 18) as distally as possible, preserving the arterial pedicles vascularizing the nasal fossae to allow repeated embolizations. Microcoils are therefore not recommended or even contra-indicated in order to avoid occluding the approach route.
Embolization of benign tumors
Most cases involve preoperative embolization and the tumors involved are mostly nasopharyngeal (angio-)fibromas (Figs. 19-21 ) and occasionally paragangliomas which may be embolized preoperatively to reduce the risk of surgical bleeding [20, 21] .
Angiofibromas occasionally have a significant vascular component from the internal carotid artery. Embolization of the internal carotid artery territory carries neurological risks and should be reserved for extremely specialized centers.
Embolization of the sphenopalatine artery is generally insufficient and devascularization requires the facial artery and ascending pharyngeal artery to be embolized, occasionally bilaterally. Embolization of the ascending pharyngeal artery can lead to paralysis of mixed nerves and should be carried out with caution with preoperative preference given to microcoils. Anastomoses may exist with the vertebrobasilar territory which should be looked for carefully during diagnostic arteriography. 
Conclusion
Embolization now currently offers huge benefit in the management of epistaxis. Its results are improved by multidisciplinary collaboration (surgeons and intensive care physicians), by strictly selecting its indications, knowledge of the vascular anatomy and mastering the process of microcatheterization and the embolization agents.
Take-home messages
• there are two types of epistaxis:
• essential, • symptomatic, secondary to underlying disease; • arterial embolization is a treatment of choice for severe refractory and symptomatic epistaxis; • full knowledge of the anatomy of the branches of the external carotid artery is an essential requirement for embolization. Its main indications are:
• essential epistaxis which is serious from the outset and life threatening or refractory after 48 hours of correct medical treatment, • severe epistaxis in ORL oncology either through invasion or postoperatively, • preoperative devascularization of hypervascular tumors (paragangliomas and nasopharyngeal fibromas), • frequent episodes of epistaxis in Rendu-Osler disease; • the treatment of benign essential epistaxis is initially local and then ''crescendo'' escalation; • hemorrhages from the anterior ethmoidal artery require surgical treatment; • the occlusion materials vary depending on the type of epistaxis:
• microparticles (from 500 to 700 microns) for essential epistaxis or Rendu-Osler disease, • microcoils or glues, particularly in secondary epistaxis or with hazardous anastomoses, • microcoils are not recommended in Rendu-Osler disease;
• microparticles can only be used when no hazardous anastomoses with the internal carotid artery or ophthalmic artery territory are present and require free flow injection under radioscopy guidance; • positioning microcoils may be a good alternative.
These have the disadvantage of permanently obstructing the artery (re-embolization is impossible in the event of recurrence); • amongst the complications of arterial embolization, cerebrovascular accident and central retinal artery obstruction are the most severe; • the complication rate in a trained operator's hands is no greater than that of surgery.
Clinical case
A 70-year-old man presents with recurrent low to moderate volume epistaxis. He has a past history of T2N0M0 conventional cell renal carcinoma, and a coronary stent in his left anterior descending artery. Clinical examination reveals a mass in the right nasal fossa. An MRI is performed including: T2-weighted images (A), Diffusion-weighted MR imaging (B), T1-weighted images (C), dynamic MR angiography (D), a time-intensity (infusion) curve (E) and T1-weighted gadolinium-chelate enhanced image (F) (Fig. 22) . D. A biopsy under a local anesthetic is justified before excision of the lesion. E. Receipt of anticoagulants or platelet antiaggregants is a contra-indication to possible embolization.
3. An arteriography is performed with a view to embolization (Fig. 23) . What are the correct answers?
A. Fig. 23a is a selective arteriography view of the external carotid artery showing partial opacification of the internal carotid artery probably due to reflux.
B. Fig. 23b is a hyperselective arteriography view of the facial artery showing a tumor blush identical in size to series (A). C. Onyx ® microcoils and calibrated spherical particles ≥ 700 m are both embolization agents which can be used. D. Fig. 23c is a hyperselective arteriography view of the ending of the internal maxillary artery post-embolization showing complete devascularization of the blush and preservation of the infra-orbital and descending palatine arteries. 
Hemodynamic stability not controlled by intensive care
Either endovascular treatment with embolization or surgery should be discussed with the ENT surgeons and intensive care physicians.
In the operating suite
Patient placed lying down with a head rest, sedated, radioscopy in position, infusion, informed and ''reassured''.
One operator, one operator's assistant and an operating suite technician.
Anesthetist/Intensive care physician for station and general anesthesia if required, monitoring and correcting hemodynamic indices. • curved hydrophilic microguides. The introducers, catheters and microcatheters should be rinsed and infused by bags and blood pressure.
On the angiography table

In the angiography suite trolley
• Microcoils suitable for the microcatheter.
• Calibrated microparticles (Luer-lock syringe prefilled to 500-700 m).
• Cyanoacrylates, (Histoacryle ® or Glubran2 ® ).
• Ethylene vinyl alcohol copolymer (Onyx ® ), rarely used in emergencies.
''Conventional'' procedure
Femoral artery approach, valve introducer rinsed and perfused, guide catheter rinsed and perfused.
• Injection into the common carotid artery after selective catheterization of the bleeding side with long series to study jugular venous return.
• Selective injection of the internal carotid artery with anteroposterior and lateral views (to study the ophthalmic artery and anterior ethmoidal artery).
• Selective injection of the external carotid artery, posteroanterior and lateral views including the nasal fossae in the field.
• Investigation for the target and identifying hazardous anastomoses: foramen lacerum artery, clival branches, pterygoid artery, foramen ovalis artery, foramen rotundum artery and in the ophthalmic artery.
• Use of a microguide and microcatheter couple from the start leaving a guide catheter at the origin of the external carotid artery. Hyperselective microcatheterization of the target (failing this the sphenopalatine artery).
• Use of arterial tracing. Do not catheterize the branches of the external carotid artery with the 0.035 guide to avoid spasm.
If hazardous anastomoses are present, place the microcatheter beyond the anastomosis but always consider the risk of reflux during embolization. If necessary, carry out proximal embolization (of the trunk) of the hazardous anastomosis using microcoils before the microparticles.
In the event of arterial spasm, to enable free flow embolization, use an in situ intra-arterial perfusion of nitrates (1 mg of Risordan ® ) with the agreement of the anesthetist-intensive care physician.
Embolization always free flow as close as possible to the target and a radioscopy control.
Angiography images are taken routinely at the end of the procedure to investigate for collateral circulation and revascularization of the target. If the sphenopalatine artery is revascularized from the facial artery, the facial artery should be embolized with very distal microspheres or microcoils.
The final check investigates for revascularization of the nasal fossa particularly by the ethmoidal arteries.
Leave the femoral introducer in situ until hemodynamic and neurological control has been confirmed clinically by the ORL team in the angiography suite.
